Key Points
NEW DELHI, Oct 6 (Reuters) - India's Norris Medicines (NORI.BO) has recalled a cough syrup and an allergy syrup that the country's federal drugs regulator had found to be toxic, its managing director said on Friday, adding that the products had only been sold in India...
The same toxins found in other Indian-made cough syrups have been linked by the World Health Organization (WHO) and other health agencies to the deaths of more than 140 children in Gambia, Uzbekistan and Cameroon since the middle of last year...
The company's Trimax Expectorant, made in January, contained 0.118% of EG, while allergy drug Sylpro Plus Syrup, made in May, had 0.171% of EG and 0.243% of DEG, according to CDSCO laboratory tests, Reuters reported last week, citing a monthly report from the regulator for August...
The WHO, which has issued several alerts about Indian medicines since last year, told Reuters the CDSCO had informed it about the Norris products...
The drug regulator of Gujarat state, where Norris is based and has two factories near to each other, has shut all its production, citing violations of good manufacturing practices after an inspection last month, Reuters reported last week citing H.G. Koshia, commissioner of Gujarat state's Food and Drug Control Administration..
You might be interested in
India finds quality issues with cough syrup linked to Cameroon deaths - sources
04, Dec, 23Indian tests of a cough syrup linked to the deaths of at least six children in Cameroon have found unidentified quality issues in at least one of the five samples picked up by authorities, two people familiar with the investigation told Reuters.